Skip to main content
OpenTrials
Completed

NCT Number: NCT01837121

a Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural China

The purpose of this study is to use a randomized controlled design to determine the impact of a SMS messaging intervention on the following outcomes among persons diagnosed with diabetic retinopathy in rural China.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Compliance Behavior Cardiovascular Diseases Diabetes Complications Diabetes Mellitus Diabetic Angiopathies Diabetic Retinopathy Endocrine System Diseases Eye Diseases Health Behavior Patient Acceptance of Health Care Patient Compliance Personal Satisfaction Retinal Diseases SMS Treatment Adherence and Compliance Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Blindness Preventment and Treatment Department, Zhongshan Ophthalmic Center

Guangzhou, Guangdong, 510060, China

About this study

SMS message reminder is a system which can sent re-visit information to remind the patient about the revisit time and address. The investigators can use the SMS system to find out if it is a useful to reduce the not-attended rate of the revisit appointment among the rural diabetic retinopathy patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all the diabetes patients who would like to join our study in 5 CREST cooperated rural hospitals.

Exclusion criteria

  • Both the patient and his/her caretakers don't have cellphone,or the one who has cellphone but don't know how to use the SMS function.
  • The first re-visit appointment time is outside our study period.

Treatment and study plan

the SMS reminder message

Other

the SMS reminder message will sent to the SMS group patients 1 week and 3 day before there appointment,to remind them the exact time and address of the revisit appointment.

Primary outcomes

  1. Not-attended rate

    Time frame: up to 1.5 years

    Compare the SMS patient not-attended rate with the control group to show the impact of SMS reminder on the compliance with scheduled follow-up visit

Secondary outcomes

  1. Knowledge about Diabetic retinopathy on a standardized examination

    Time frame: up to 1.5 years

    Using a questionnaire about the comprehensive eye exam and Diabetic retinopathy to compare Knowledge about Diabetic retinopathy on a standardized examination between the SMS group and the control group

  2. Presenting vision

    Time frame: up to 1.5 years

    Presenting vision(Best corrected visual acuity) in the better-seeing and worse-seeing eyes of the two group

  3. Loss of presenting vision

    Time frame: up to 1.5 years

    Loss of presenting vision(Best corrected visual acuity) in better-seeing eye thought due to Diabetic retinopathy

  4. Satisfaction with care

    Time frame: up tp 1.5 years

    Using a patient satisfaction questionnaire to compare satisfaction with care between the SMS group and the control group

Sponsors and collaborators

Lead sponsor

Sun Yat-sen University

Other

Collaborators

  • Orbis
  • The World Diabetes Foundation

Registry information

Official study title

a Randomized Controlled Trail to Determine the Impact of a SMS Reminder Among Diabetic Retinopathy Patients in Rural China

Acronym: SMS

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Apr 22, 2013
Registry last updated
Jan 9, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.